GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dong-E-E-Jiao Co 000423.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

50.40

-0.88%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥6.64bn

FY2016FY2025

Net income

CN¥1.74bn

FY2016FY2025

Free cash flow

CN¥2.30bn

FY2016FY2025

Shareholders' equity

CN¥10.34bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥6.64bnCN¥5.92bnCN¥4.72bnCN¥4.04bnCN¥3.85bnCN¥3.41bnCN¥2.97bnCN¥7.34bnCN¥7.37bnCN¥6.32bn
Gross profitCN¥4.76bnCN¥4.29bnCN¥3.32bnCN¥2.75bnCN¥2.20bnCN¥1.65bnCN¥1.40bnCN¥4.83bnCN¥4.78bnCN¥4.21bn
Research and developmentCN¥260.1mCN¥173.8mCN¥173.2mCN¥137.7mCN¥147.7mCN¥153.6mCN¥205.4mCN¥240.8mCN¥225.5mCN¥167.2m
Operating incomeCN¥1.94bnCN¥1.85bnCN¥1.36bnCN¥914.9mCN¥568.8mCN¥152.1m−CN¥523.3mCN¥2.45bnCN¥2.41bnCN¥2.16bn
Net incomeCN¥1.74bnCN¥1.56bnCN¥1.15bnCN¥780.0mCN¥440.4mCN¥43.3m−CN¥454.8mCN¥2.08bnCN¥2.04bnCN¥1.85bn
Diluted earnings per share2.722.421.791.210.680.07-0.703.193.132.83

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥13.38bnCN¥13.10bnCN¥13.31bnCN¥12.63bnCN¥11.63bnCN¥10.99bnCN¥11.70bnCN¥13.87bnCN¥12.38bnCN¥9.95bn
Cash and short-term investmentsCN¥9.08bnCN¥8.54bnCN¥8.34bnCN¥7.23bnCN¥5.72bnCN¥2.89bnCN¥2.34bnCN¥4.84bnCN¥4.67bnCN¥3.71bn
Total liabilitiesCN¥3.02bnCN¥2.76bnCN¥2.57bnCN¥2.28bnCN¥1.63bnCN¥1.22bnCN¥1.67bnCN¥2.54bnCN¥2.50bnCN¥1.56bn
DebtCN¥38.6mCN¥21.7mCN¥31.0mCN¥42.4mCN¥47.6mCN¥37.1mCN¥312.3mCN¥267.1mCN¥31.2mCN¥146.9m
Shareholders' equityCN¥10.34bnCN¥10.32bnCN¥10.72bnCN¥10.33bnCN¥9.97bnCN¥9.73bnCN¥9.98bnCN¥11.30bnCN¥9.84bnCN¥8.36bn
Shares outstanding638m643m644m647m644m644m648m654m654m654m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥2.39bnCN¥2.17bnCN¥1.95bnCN¥2.14bnCN¥2.80bnCN¥800.8m−CN¥1.12bnCN¥1.01bnCN¥1.76bnCN¥624.6m
Capital spending−CN¥82.7m−CN¥97.4m−CN¥54.5m−CN¥45.6m−CN¥24.7m−CN¥102.8m−CN¥336.1m−CN¥249.3m−CN¥313.9m−CN¥350.6m
Free cash flowCN¥2.30bnCN¥2.07bnCN¥1.90bnCN¥2.10bnCN¥2.78bnCN¥698.0m−CN¥1.46bnCN¥759.7mCN¥1.44bnCN¥274.0m
Dividends paid−CN¥1.64bn−CN¥1.88bn−CN¥758.7m−CN¥425.1m−CN¥191.7m−CN¥132.8m−CN¥715.3m−CN¥620.8m−CN¥613.4m−CN¥528.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.34bnCN¥1.81bnCN¥1.93bnCN¥1.72bnCN¥1.33bnCN¥1.72bnCN¥1.59bnCN¥1.58bn
Gross profitCN¥990.7mCN¥1.37bnCN¥1.37bnCN¥1.28bnCN¥967.5mCN¥1.27bnCN¥1.08bnCN¥1.19bn
Operating incomeCN¥428.4mCN¥529.3mCN¥573.7mCN¥455.0mCN¥470.7mCN¥508.2mCN¥506.2mCN¥463.9m
Net incomeCN¥405.6mCN¥454.8mCN¥464.9mCN¥456.1mCN¥392.7mCN¥425.0mCN¥405.0mCN¥413.6m
Diluted earnings per share0.640.710.730.710.620.670.630.64
Cash from operations——CN¥1.02bnCN¥353.0mCN¥1.29bn−CN¥279.0mCN¥1.46bnCN¥520.0m
Capital spending−CN¥169.0m−CN¥44.0m−CN¥38.0m−CN¥21.0m−CN¥10.0m−CN¥11.0m−CN¥34.0m−CN¥20.0m
Free cash flow——CN¥985.0mCN¥332.0mCN¥1.28bn−CN¥290.0mCN¥1.42bnCN¥500.0m
Total assetsCN¥12.71bnCN¥13.55bnCN¥13.38bnCN¥12.75bnCN¥12.78bnCN¥13.31bnCN¥13.10bnCN¥12.72bn
Cash and short-term investments——CN¥9.08bnCN¥8.17bnCN¥8.74bnCN¥8.23bnCN¥8.54bnCN¥7.81bn
Debt———CN¥57.9mCN¥13.2mCN¥15.4m——
Shareholders' equityCN¥10.16bnCN¥10.79bnCN¥10.34bnCN¥9.95bnCN¥10.31bnCN¥10.74bnCN¥10.32bnCN¥9.91bn

Financial ratios

Data as of 21 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2015FY2008
Gross margin71.6%72.5%70.4%68.0%57.2%48.5%——
Operating margin29.2%31.2%28.8%22.6%14.8%4.5%——
Net margin26.2%26.3%24.4%19.3%11.4%1.3%——
Return on equity16.8%15.1%10.7%7.6%4.4%0.4%——
Return on assets13.0%11.9%8.6%6.2%3.8%0.4%——
Free cash flow yield8.5%7.7%6.8%7.4%9.6%3.1%——
Revenue growth12.2%25.6%16.7%5.0%12.9%14.8%——
Earnings growth11.7%35.3%47.5%77.1%917.4%-109.5%——
Current ratio3.69x3.95x4.38x4.66x6.02x7.41x——
Debt to equity—0.00x0.00x0.00x0.00x—0.01x0.00x
Equity ratio77.2%78.8%80.6%81.8%85.8%88.5%——
Interest coverage284.78x242.01x342.43x165.74x91.21x9.87x——
R&D as a share of sales3.9%2.9%3.7%3.4%3.8%4.5%——
Buybacks as a share of market value0.8%0.1%0.4%-0.4%0.0%0.6%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.0%14.3%2.0%
Operating income28.5%66.4%0.1%
Net income30.6%109.3%0.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin72.0%70.9%66.4%65.0%
Operating margin30.2%28.4%23.7%26.2%
Net margin26.2%24.5%20.0%22.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings18.025.927.633.771.3—-50.412.419.319.0
Price to sales4.76.86.76.58.27.37.73.55.35.6

Dividends and splits

Per share, in the currency the company pays

Paid for 26 years. Last went ex-dividend on 25 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.4352.5432.9311.1780.660.3050.2031.01
  • 1-to-1 reverse split · 1 Jun 2007
  • 3-for-2 split · 17 Jun 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.